Your browser doesn't support javascript.
loading
Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.
Folkersen, Lasse; Fauman, Eric; Sabater-Lleal, Maria; Strawbridge, Rona J; Frånberg, Mattias; Sennblad, Bengt; Baldassarre, Damiano; Veglia, Fabrizio; Humphries, Steve E; Rauramaa, Rainer; de Faire, Ulf; Smit, Andries J; Giral, Philippe; Kurl, Sudhir; Mannarino, Elmo; Enroth, Stefan; Johansson, Åsa; Enroth, Sofia Bosdotter; Gustafsson, Stefan; Lind, Lars; Lindgren, Cecilia; Morris, Andrew P; Giedraitis, Vilmantas; Silveira, Angela; Franco-Cereceda, Anders; Tremoli, Elena; Gyllensten, Ulf; Ingelsson, Erik; Brunak, Søren; Eriksson, Per; Ziemek, Daniel; Hamsten, Anders; Mälarstig, Anders.
Afiliação
  • Folkersen L; Department of Systems Biology, Technical University of Denmark, Copenhagen, Denmark.
  • Fauman E; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Sabater-Lleal M; Pfizer Worldwide Research & Development, Cambridge, Massachusetts, United States of America.
  • Strawbridge RJ; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Frånberg M; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Sennblad B; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Baldassarre D; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Veglia F; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy.
  • Humphries SE; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Rauramaa R; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • de Faire U; British Heart Foundation Laboratories, University College of London, Department of Medicine, Rayne Building, London, United Kingdom.
  • Smit AJ; Foundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
  • Giral P; Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Kurl S; Department of Medicine, University Medical Center Groningen, Groningen, the Netherlands.
  • Mannarino E; Assistance Publique - Hopitaux de Paris; Service Endocrinologie-Metabolisme, Groupe Hôpitalier Pitie-Salpetriere, Unités de Prévention Cardiovasculaire, Paris, France.
  • Enroth S; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.
  • Johansson Å; Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy.
  • Enroth SB; Department of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden.
  • Gustafsson S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden.
  • Lind L; Department of Internal Medicine, Uppsala University Hospital, Uppsala, Sweden.
  • Lindgren C; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Morris AP; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Giedraitis V; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Silveira A; Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom.
  • Franco-Cereceda A; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Tremoli E; Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Gyllensten U; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università di Milano, Milan, Italy.
  • Ingelsson E; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Eriksson P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden.
  • Ziemek D; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Hamsten A; Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, United States of America.
  • Mälarstig A; Department of Systems Biology, Technical University of Denmark, Copenhagen, Denmark.
PLoS Genet ; 13(4): e1006706, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28369058
Recent advances in highly multiplexed immunoassays have allowed systematic large-scale measurement of hundreds of plasma proteins in large cohort studies. In combination with genotyping, such studies offer the prospect to 1) identify mechanisms involved with regulation of protein expression in plasma, and 2) determine whether the plasma proteins are likely to be causally implicated in disease. We report here the results of genome-wide association (GWA) studies of 83 proteins considered relevant to cardiovascular disease (CVD), measured in 3,394 individuals with multiple CVD risk factors. We identified 79 genome-wide significant (p<5e-8) association signals, 55 of which replicated at P<0.0007 in separate validation studies (n = 2,639 individuals). Using automated text mining, manual curation, and network-based methods incorporating information on expression quantitative trait loci (eQTL), we propose plausible causal mechanisms for 25 trans-acting loci, including a potential post-translational regulation of stem cell factor by matrix metalloproteinase 9 and receptor-ligand pairs such as RANK-RANK ligand. Using public GWA study data, we further evaluate all 79 loci for their causal effect on coronary artery disease, and highlight several potentially causal associations. Overall, a majority of the plasma proteins studied showed evidence of regulation at the genetic level. Our results enable future studies of the causal architecture of human disease, which in turn should aid discovery of new drug targets.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Sanguíneas / Biomarcadores / Doenças Cardiovasculares / Locos de Características Quantitativas Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Sanguíneas / Biomarcadores / Doenças Cardiovasculares / Locos de Características Quantitativas Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article